135 related articles for article (PubMed ID: 8947058)
1. Neutrophil proteinases and rhDNase therapy in cystic fibrosis.
Vogelmeier C; Döring G
Eur Respir J; 1996 Nov; 9(11):2193-5. PubMed ID: 8947058
[No Abstract] [Full Text] [Related]
2. Aerosolized rhDNase in cystic fibrosis: effect on leucocyte proteases in sputum.
Rochat T; Pastore FD; Schlegel-Haueter SE; Filthuth I; Auckenthaler R; Belli D; Suter S
Eur Respir J; 1996 Nov; 9(11):2200-6. PubMed ID: 8947060
[TBL] [Abstract][Full Text] [Related]
3. Effect of DNase on the activity of neutrophil elastase, cathepsin G and proteinase 3 in the presence of DNA.
Duranton J; Belorgey D; Carrère J; Donato L; Moritz T; Bieth JG
FEBS Lett; 2000 May; 473(2):154-6. PubMed ID: 10812064
[TBL] [Abstract][Full Text] [Related]
4. Purulent sputum as a source of neutrophil proteins.
Johnston TW; Wisdom GB
Biochem Soc Trans; 1994 Feb; 22(1):48S. PubMed ID: 8206273
[No Abstract] [Full Text] [Related]
5. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
6. Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients.
Moore JE; Shaw A; Millar BC; Martin SL; Murphy PG; Downey DG; Ennis M; Elborn JS
Br J Biomed Sci; 2004; 61(3):146-7. PubMed ID: 15462261
[No Abstract] [Full Text] [Related]
7. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
8. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy.
Papayannopoulos V; Staab D; Zychlinsky A
PLoS One; 2011; 6(12):e28526. PubMed ID: 22174830
[TBL] [Abstract][Full Text] [Related]
10. The protease-antiprotease battle in the cystic fibrosis lung.
Balfour-Lynn IM
J R Soc Med; 1999; 92 Suppl 37(Suppl 37):23-30. PubMed ID: 10472249
[No Abstract] [Full Text] [Related]
11. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
Costello CM; O'Connor CM; Finlay GA; Shiels P; FitzGerald MX; Hayes JP
Thorax; 1996 Jun; 51(6):619-23. PubMed ID: 8693445
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.
Döring G; Frank F; Boudier C; Herbert S; Fleischer B; Bellon G
J Immunol; 1995 May; 154(9):4842-50. PubMed ID: 7722333
[TBL] [Abstract][Full Text] [Related]
13. DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice.
Cantin AM
Am J Respir Crit Care Med; 1998 Feb; 157(2):464-9. PubMed ID: 9476859
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium.
Hiemstra PS; van Wetering S; Stolk J
Eur Respir J; 1998 Nov; 12(5):1200-8. PubMed ID: 9864022
[TBL] [Abstract][Full Text] [Related]
15. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2.
Mulligan MS; Desrochers PE; Chinnaiyan AM; Gibbs DF; Varani J; Johnson KJ; Weiss SJ
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11523-7. PubMed ID: 7903451
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
17. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases.
Owen CA; Campbell MA; Sannes PL; Boukedes SS; Campbell EJ
J Cell Biol; 1995 Nov; 131(3):775-89. PubMed ID: 7593196
[TBL] [Abstract][Full Text] [Related]
18. Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis.
Regelmann WE; Siefferman CM; Herron JM; Elliott GR; Clawson CC; Gray BH
Pediatr Pulmonol; 1995 Jan; 19(1):1-9. PubMed ID: 7675551
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil collagenase in sputum from patients with cystic fibrosis.
Power C; O'Connor CM; MacFarlane D; O'Mahoney S; Gaffney K; Hayes J; FitzGerald MX
Am J Respir Crit Care Med; 1994 Sep; 150(3):818-22. PubMed ID: 8087357
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
